These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 10690524)

  • 41. Molecular and biological analysis of carcinoma of the small intestine: beta-catenin gene mutation by interstitial deletion involving exon 3 and replication error phenotype.
    Murata M; Iwao K; Miyoshi Y; Nagasawa Y; Ohta T; Shibata K; Oda K; Wada H; Tominaga S; Matsuda Y; Ohsawa M; Nakamura Y; Shimano T
    Am J Gastroenterol; 2000 Jun; 95(6):1576-80. PubMed ID: 10894600
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Expression of beta-catenin and E-cadherin in the adenoma-carcinoma sequence of the stomach.
    Kim HS; Hong EK; Park SY; Kim WH; Lee HS
    Anticancer Res; 2003; 23(3C):2863-8. PubMed ID: 12926124
    [TBL] [Abstract][Full Text] [Related]  

  • 43. P53 gene and Wnt signaling in benign neoplasms: beta-catenin mutations in hepatic adenoma but not in focal nodular hyperplasia.
    Chen YW; Jeng YM; Yeh SH; Chen PJ
    Hepatology; 2002 Oct; 36(4 Pt 1):927-35. PubMed ID: 12297840
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Expression of classic cadherins type I in urothelial neoplastic progression.
    Rieger-Christ KM; Cain JW; Braasch JW; Dugan JM; Silverman ML; Bouyounes B; Libertino JA; Summerhayes IC
    Hum Pathol; 2001 Jan; 32(1):18-23. PubMed ID: 11172290
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Infrequent mutations of the WT1 gene in primary cancers of the adult urinary tract.
    Kageyama Y; Yamamura Y; Oshima H; Ikawa Y
    Jpn J Clin Oncol; 1995 Oct; 25(5):173-8. PubMed ID: 7474403
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Beta-catenin expression and its significance for metastasis in curatively operated rectum carcinoma].
    Günther K; Brabletz T; Dworak O; Reymond MA; Köckerling F; Ballhausen W; Hohenberger W
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():1380-2. PubMed ID: 9931888
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Aberrant expression of beta-catenin and mutation of exon 3 of the beta-catenin gene in renal and urothelial carcinomas.
    Zhu X; Kanai Y; Saito A; Kondo Y; Hirohashi S
    Pathol Int; 2000 Dec; 50(12):945-52. PubMed ID: 11123760
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Downregulation of HNF-1B in renal cell carcinoma is associated with tumor progression and poor prognosis.
    Buchner A; Castro M; Hennig A; Popp T; Assmann G; Stief CG; Zimmermann W
    Urology; 2010 Aug; 76(2):507.e6-11. PubMed ID: 20538322
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Beta-catenin mutations in human prostate cancer.
    Voeller HJ; Truica CI; Gelmann EP
    Cancer Res; 1998 Jun; 58(12):2520-3. PubMed ID: 9635571
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Activation of the beta-catenin gene in primary hepatocellular carcinomas by somatic alterations involving exon 3.
    Miyoshi Y; Iwao K; Nagasawa Y; Aihara T; Sasaki Y; Imaoka S; Murata M; Shimano T; Nakamura Y
    Cancer Res; 1998 Jun; 58(12):2524-7. PubMed ID: 9635572
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cyclin A overexpression in carcinoma of the renal pelvis and ureter including dysplasia: immunohistochemical findings in relation to prognosis.
    Furihata M; Ohtsuki Y; Sonobe H; Shuin T; Yamamoto A; Terao N; Kuwahara M
    Clin Cancer Res; 1997 Aug; 3(8):1399-404. PubMed ID: 9815824
    [TBL] [Abstract][Full Text] [Related]  

  • 52. RAR-beta(1) overexpression in chromophobe renal cell carcinoma: a novel target for therapeutic intervention?
    Goelden U; Ukena SN; Pfoertner S; Hofmann R; Buer J; Schrader AJ
    Exp Oncol; 2005 Sep; 27(3):220-4. PubMed ID: 16244585
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Complex cadherin expression in renal cell carcinoma.
    Shimazui T; Giroldi LA; Bringuier PP; Oosterwijk E; Schalken JA
    Cancer Res; 1996 Jul; 56(14):3234-7. PubMed ID: 8764114
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gene expression and promoter methylation of the XIAP-associated Factor 1 in renal cell carcinomas: correlations with pathology and outcome.
    Kempkensteffen C; Hinz S; Schrader M; Christoph F; Magheli A; Krause H; Schostak M; Miller K; Weikert S
    Cancer Lett; 2007 Sep; 254(2):227-35. PubMed ID: 17449173
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Metastatic renal cell carcinoma to the bladder: a clinicopathologic and immunohistochemical study.
    Sim SJ; Ro JY; Ordonez NG; Park YW; Kee KH; Ayala AG
    Mod Pathol; 1999 Apr; 12(4):351-5. PubMed ID: 10229498
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [p53 mutation in phenacetin-induced urothelial carcinomas].
    Petersen I; Ohgaki H; Ludeke BI; Kleihues P
    Verh Dtsch Ges Pathol; 1993; 77():252-5. PubMed ID: 7511292
    [TBL] [Abstract][Full Text] [Related]  

  • 57. beta-catenin expression and mutational analysis in renal cell carcinomas.
    Kim YS; Kang YK; Kim JB; Han SA; Kim KI; Paik SR
    Pathol Int; 2000 Sep; 50(9):725-30. PubMed ID: 11012986
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Transitional cell carcinoma of the upper urinary tract: analysis of morphology and distribution for surgical management.
    Fujimoto H; Tobisu K; Mizutani T; Sakamoto M; Kakizoe T
    Jpn J Clin Oncol; 1993 Oct; 23(5):303-8. PubMed ID: 8230755
    [TBL] [Abstract][Full Text] [Related]  

  • 59. p53 and HER-2 alterations in renal cell carcinoma.
    Zhang XH; Takenaka I; Sato C; Sakamoto H
    Urology; 1997 Oct; 50(4):636-42. PubMed ID: 9338750
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Expression of the retinoblastoma gene product in renal tumors.
    Presti JC; Reuter VE; Cordon-Cardo C; Motzer RJ; Albino AP; Jhanwar SC; Nanus DM
    Anticancer Res; 1996; 16(2):549-56. PubMed ID: 8687097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.